The 22 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 64.13, with a high estimate of 83.12 and a low estimate of 47.24. The median estimate represents a +26.14% increase from the last price of 50.84.
The current consensus among 26 polled investment analysts is to Buy stock in AstraZeneca PLC. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.67
Reporting Date Apr 30
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.